Uncategorized
VIDEO: Kala CMO updates Eysuvis dry eye treatment progress
In this Healio Video Perspective, Kim Brazzell, MD, PhD, chief medical officer for Kala Pharmaceuticals, gives an update on the progress of Eysuvis for the short-term treatment of dry eye disease, which the company expects to launch by the end of 2020.